Low-carbohydrate/high-protein diet improves diastolic cardiac function and the metabolic syndrome in overweight-obese patients with type 2 diabetes

IJC Metabolic and Endocrine

Volumn 2, Issue , 2014, Pages 11-18

  Von Bibra, H ^a   Wulf, G ^b   St John Sutton, M ^c   Pfutzner A ^d   Schuster, T ^e   Heilmeyer, P ^b  

^a KLINIKUM BOGENHAUSEN   (Germany)

^b Rehaklinik Überruh Isny ^*  (Germany)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d IKFE   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Diastolic cardiac function; Insulin resistance; Low carbohydrate diet; Metabolic syndrome; Postprandial metabolism; Type 2 diabetes

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE MONITORING; CALORIC INTAKE; CLINICAL ARTICLE; DIABETIC CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; EXERCISE; FEMALE; GLYCEMIC INDEX; HEART FUNCTION; HUMAN; INSULIN RESISTANCE; LOW CARBOHYDRATE DIET; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN DIET; TRAINING;

EID: 84895446905     PISSN: 22147624     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcme.2013.12.001     Document Type: Article

References (40)

1. Schocken D.D., Benjamin E.J., Fonarow G.C., et al. Prevention of heart failure: a scientific statement of the American Heart Association Councils on epidemiology and prevention, clinical cardiology, cardiovascular nursing, and high blood pressure research; quality of care and outcomes research interdisciplinary working group; and functional genomics and translational biology interdisciplinary working group. Circulation 2008, 117:2544-2565.
2. Thrainsdottir I.S., Aspelund T., Gudnason V., et al. Increasing glucose levels and BMI predict future heart failure. Experience from the Reykjavik Study. Eur J Heart Fail 2007, 9:1051-1057.
3. Ingelsson E., Sundstrom J., Arnlov J., Zethelius B., Lind L. Insulin resistance and risk of congestive heart failure. JAMA 2005, 294:334-341.
4. Stahrenberg R., Edelmann F., Mende M., et al. Association of glucose metabolism with diastolic function along the diabetic continuum. Diabetologia 2010, 53:1331-1340.
5. Borlaug B.A., Paulus W.J. Heart failure preserved ejection fraction: pathophysiology, diagnosis and treatment. Eur Heart J 2011, 32:670-679.
6. Nagueh S.F., Middleton K.J., Kopelen H.A., et al. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997, 30:1527-1533.
7. Paulus W.J., Tschope C., Sanderson J.E., et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007, 28:2539-2550.
8. von Bibra H., St.John Sutton M. Diastolic dysfunction in diabetes and metabolic syndrome-diagnostic and prognostic potential. Diabetologia 2010, 53:1033-1045.
9. von Bibra H., Hansen A., Dounis V., Bystedt T., Malmberg K., Rydén L. Insulin based improved metabolic control augments myocardial diastolic function and perfusion in patients with type 2 diabetes mellitus. Heart 2004, 90:1483-1484.
10. van der Meer R.W., Rijzewijk L.J., de Jong H.W., et al. Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus. Circulation 2009, 119:2069-2077.
11. von Bibra H., Diamant M., Scheffer P.G., Siegmund T., Schumm-Draeger P.-M. Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with a reduction of oxidative stress and inflammation in patients with type 2 diabetes mellitus. Diab Vasc Dis Res 2008, 5:310-318.
12. Hammer S., Snel M., Lamb H.J., et al. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J Am Coll Cardiol 2008, 52:1006-1012.
13. Pereira G., Swain J., Goldlfine A.B., Rifai N., Ludwig D.S. Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss. JAMA 2004, 292:2482-2490.
14. Accurso A., Bernstein R.K., Dahlqvist A., et al. Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Nutr Metab 2008, 5:9-17.
15. Ajala O., English P., Pinkney J. Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr 2013, 97:505-516.
16. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997, 20:1183-1197.
17. Heilmeyer P. Die LOGI-Methode. Ernahr Med 2008, 23:20-25.
18. Pfützner A., Kunt T., Hohberg C., et al. Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes. Diabetes Care 2004, 27:682-687.
19. Safinowski M., Wilhelm B., Reimer T., et al. Determination of nitrotyrosine concentrations in plasma samples of diabetes mellitus patients by four different immunoassays leads to contradictive results and disqualifies the majority of the tests. Clin Chem Lab Med 2009, 47:483-488.
20. Pfützner A., Karagiannis E., Löbig M., Armbruster F.P., Hanefeld M., Forst T. Differences in the determination and interpretation of oxidized LDL cholesterol by two ELISA assays-a clinical evaluation with samples from the PIOstat study. Clin Lab 2009, 55:275-281.
21. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.R., Turner R.C. Homeostasis model assessment: insulin resistance and ß-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
22. McLaughlin T., Reaven G., Abbasi F., et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?. Am J Cardiol 2005, 96:399-404.
23. von Bibra, Siegmund T., Ceriello A., Volozhyna M., Schumm-Draeger P.M. Optimized postprandial glucose control is associated with improved cardiac/vascular function-comparison of three insulin regimens in well controlled type 2 diabetes. Horm Metab Res 2009, 41:109-115.
24. van Heerebeek L., Hamdani N., Handoko L., et al. Diastolic stiffness of the failing heart: importance of fibrosis, advanced glycation endproducts and myocyte resting tension. Circulation 2008, 117:43-51.
25. Ouwens D.M., Diamant M. Myocardial insulin action and the contribution of insulin resistance to the pathogenesis of diabetic cardiomyopathy. Arch Physiol Biochem 2004, 113:76-85.
26. De las Fuentes L., Brown A.L., Mathews S.J., et al. Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. Eur Heart J 2007, 28:553-559.
27. Fang Z.Y., Prins J.B., Marwick T.H. Diabetic cardiomyopathy: evidence, mechanisms and therapeutic implications. Endocr Rev 2004, 25:543-567.
28. Witteles R.M., Fowler M.B. Insulin-resistant cardiomyopathy. Clinical evidence, mechanisms and treatment options. J Am Coll Cardiol 2008, 51:93-102.
29. Kosmala W., O'Moore-Sullivan T., Plaksej R., Prezwlocka-Kosmala M., Marwick T.H. Improvement of left ventricular function by lifestyle intervention in obesity: contributions of weight loss and reduced insulin resistance. Diabetologia 2009, 52:2306-2311.
30. Wong C.Y., Byrne N.M., O'Moore-Sullivan T., et al. Effect of weight loss due to lifestyle intervention on subclinical cardiovascular dysfunction in obesity (body mass index>30kg/m2). Am J Cardiol 2006, 98:1593-1598.
31. Hordern M.D., Coombes J.S., Cooney L.M., Jeffriess L., Prins J.B., Marwick T.H. Effects of exercise intervention on myocardial function in type 2 diabetes. Heart 2008, 95:1343-1349.
32. Boudina S., Abel E.D. Diabetic cardiomyopathy revisited. Circulation 2007, 115:3213-3223.
33. von Bibra H., St.John Sutton M., Schuster T., Ceriello A., Siegmund T., Schumm-Draeger P.M. Oxidative stress after a carbohydrate meal contributes to the deterioration of diastolic cardiac function in non-hypertensive, insulin-treated patients with moderately well controlled type 2 diabetes. Horm Metab Res 2013, 45:449-455.
34. Gannon M.C., Nuttal F.Q. Effect of high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabetes. Diabetes 2004, 53:2375-2382.
35. Shai I., Schwarzfuchs D., Henkin Y., et al. Weight loss with a low carb, Mediterranean, or low fat diet. New Engl J Med 2008, 359:229-241.
36. Rijzewijk L.J., van der Meer R.W., Smit J.W.A., et al. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 2008, 52:1793-1799.
37. Chiasson J.L. Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM) trial. Endocr Pract 2006, 12(Suppl. 1):25-30.
38. Santos F.L., Esteves S.S., da Costa Pereira A., Yanca W.S., Nunes J.P.L. Systematic review and meta-analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors. Obes Rev 2012, 13:1048-1066.
39. von Bibra H., St.John Sutton M. Impact of diabetes on postinfarction heart failure and left ventricular remodeling. Curr Heart Fail Rep 2011, 8:242-251.
40. Esposito K., Maiorino M.I., Di Palo C., et al. Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes. Ann Int Med 2009, 151:306-314.